Member Info for physical

After Hours up %8... something brewing?

There is a picture on this discussion board, of GC posing in front of the company.
https://stocktwits.com/terryzana/message/297216224
The board itself is very toxic and I don't recommend to anyone, but the picture got my attention. Could it be true? Looks a bit like photoshop also...

I have listened to it all. Some well thought out questions. Dr. K was on point, but I could feel he was holding himself back on some answers, not to say anything that would be perceived as speculation. Big Pharma interest in Tiziana repeatedly emphasised.

Where's that dude going on and on about a flag pole formation and all?

You were spot on, mate!

I remember reading on an RNS or somewhere, one of the exects quoted, stating a distinction between the summary data announced Early Feb, which would be followed by the full data set of the Brazil trial. I cannot remember where though...

This amount of brazen radio silence could only mean two things for us mere mortals without insider information:

1. The data published earlier this month hasn't reach its intended audience / or wasn't as impressive as expected.

2. We are in the NDA zone! Price being suppressed and a Takeover / JV / or some kind of partnership imminent!

There really isn't any other option here in my honest opinion. Place your bets!

Look at the story of Immunome $IMNM, currently up %180 Today, tell me it doesn't resemble our TILS here

I have a FEELING that the partnership regarding Covid-19 side of things will be with MERCK. Having failed in the Vaccine race badly, they need a win and they need it quick.

Disclaimer: its just a guess.

I guess you either sell as an investor, or you hold it long enough to see yourself become a ramper :)

The conference is ongoing, but registration fee is $995. I would instead buy a few more stocks, as I already know what they are publishing there. We all know, it was in the Brazil RNS. We might see a spike on Friday.

You don't simply speak in a conference where your

competition, your friends, your colleagues, your believers and doubters, people who's careers you envy, people who envy your career, industry professionals, potential buyers, potential employers, potential employees, and press

watches you, unless you have something important to show off!

I am not in Health or Medical industry but I know what kind of an appearance one has to make and what kind of an impression one has to leave in the audience's minds and hearts. I assume our investment has a great deal of boasting to do, to perform in such an event.

Good news coming about the Vaccines from around the globe, which carries our HYVE back to £0.8Bn - £1Bn mcap ranges. There might be some profit taking around here and there, pulling the share price down, but nothing to be demoralised about, remember many holders got shares cheap from the rights issue, and the Covid dips of around 0.60p.

Another interesting article on the FT today, talking about swift, on-premises testing.

"...Ministers are considering plans for “test with a ticket”, where customers will be offered a quick turnround test for Covid-19 as part of attending a concert or performance. “Those kind of things can really help us open up things with bigger numbers, where social distancing affects their ability to operate in an economic way,” one individual with knowledge of the plans said. But some Whitehall officials said the plans remained “at the very early stages” and “such measures would be part of efforts to reduce social distancing when we’re in a much better place”.

This could boost confidence and make real exhibitions happen sooner than we think! My two cents is this, along with Rolls Royce is the best Covid recovery plays, much better than the travel stocks which have already appreciated

FTSE performance satisfying amid Covid - 19 Vaccine news, big news all around the globe, big buys of vaccines and the Vaccine Gold Rush nearing its peak.

-From Ft Article "...Since the start of 2020 Novavax has rocketed more than 6,400 per cent, Moderna is up over 850 per cent and BioNTech more than 190 per cent..."

As the vaccine craze peaks, a new and bigger craze will begin, the Covid MEDS GOLD RUSH. TILS resembling of Novavax, relatively smaller cap, up for a big rise.

Looking from a Covid-19 perspective, I think a more fundamental issue here is the mABs Cure Tiziana makes will mean bad business for the Trillion Dollars vaccine economy. Less people would want to get vaccinated if they could just take a medicine for it. Retrospectively, knowing the greed bastards that Big Pharma is, they would want to sell BOTH vaccine and cure, hence the talk these days "covid is here to stay". I am certain we will see big pharma involvement into Tiziana very soon, in fact I have bet on it like most of us lol.

I guess we just have to wait out the vaccine story to get boring.

We were fed up with all the Accustem talk, now we have to deal with advertisement of other stocks also!

I think nasdaq open will raise TILS today.
GLA

Someone is buying everything that touches £TILS 135 or $TLSA 385.

I hadn't watched it last week. I guess I needed it more today. Gave me strength to hold! Have a look if you haven't already seen it...

https://youtu.be/GKfE5uSz8Pw

BP82, Intresting news you got there, thanks for sharing.

I see this as a win no matter what:

1. Bullcrap - The news is nonexistent but it means the idea of treating the lungs immune response instead of the virus is getting mainstream traction, point TILS.

2. Competition got there first - TILS will be second to market, less problems, more natural, free publicity and more big pharma appetite.

3. Its actually TILS - Just kidding. If only.

I don't know where you source that information, but Dubai 2020 Expo and Tokyo Olympics 2020 WILL be held this year, according to their boards. These are much bigger scale events HYVE can only dream of, and they are being done. Moreover, HYVE has organised shows DURING the Pandemic in many different regions around the globe, I highly doubt they will stop now.

With a claim like this, either show your sources (better not be the Guardian or smth) or risk being perceived as someone who missed their entry point around 70p, before the November Vaccine news spike, thus trying to pull the price down.

340p a year ago. (Before acquiring shoptalk, groceryshop and the virtual thingy).

Hyve is purely an organizer, they don't hold venues or any asset that chews up cash as a maintenance. I assume that overheads (mainly salaries) and minimal marketing spending (%20 of what it was when the shows were running) should be the only real cost here.

In fact, they must have had so much more cash than expected after the RI and cost saving measures, that they dished out some millions recently to buy a virtual expo concept. Its like Tinder, but you get connected to socially and virtually inept business people instead.

I have a follow-up question.

If my holding is already borrowed for shorting, what happens to the sort position / short broker when I put a sell order?